tiprankstipranks
Control Bionics Expands with NeuroStrip Commercial Agreements
Company Announcements

Control Bionics Expands with NeuroStrip Commercial Agreements

Control Bionics Ltd. (AU:CBL) has released an update.

Stay Ahead of the Market:

Control Bionics Limited, a leader in EMG medical device technology, is set to expand its market presence with its NeuroStrip® technology securing commercial agreements in U.S. sports performance and Japanese rehabilitation sectors. The company is hosting an online Investor Briefing to discuss these developments and provide a company update. This move marks a significant step for Control Bionics in leveraging its patented technology across new markets.

For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles